研究成果 (81)

排序依據：日期 | 題名

10 | 25 | 50 | 100

1/9

3 A B C D E F G H I L M N O P Q R S T 全部

30 Immunotherapy in advanced NSCLC - from the 'tsunami' of therapeutic knowledge to a clinical practice algorithm: results from an international expert panel meeting of the Italian Association of Thoracic Oncology (AIOT)
de Marinis F, Ciardiello F, Baas P, Crinò L, Giaccone G, Grossi F, Hellmann MD, Mok TSK, Lena H, Paz-Ares L, Rodriguez-Abreu D, Von Pavel J, Gridelli C ( 2018 )
ESMO Open
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1136/esmoopen-2017-000298
Ablative Chemoembolization for Hepatocellular Carcinoma: A Prospective Phase I Case-Control Comparison with Conventional Chemoembolization
Simon Chun Ho Yu, Stephen Lam Chan, Kit Fai Lee, Joyce Wai Yi Hui, Edwin Pun Hui, Cheuk Man Chu, Anthony Wing-hung Chan, Sunny Cheung, Leung Li, John Wong, Winnie Ming Ming Yeo ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1148/radiol.2017170154
Adherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancer
Lei YY, Ho SC, Cheng A, Kwok C, Lee CI, Cheung KL, Lee R, Loong HHF, He YQ, Yeo W ( 2018 )
Journal of the National Comprehensive Cancer Network
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.6004/jnccn.2017.7202
Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI
Mann H, Andersohn F, Bodnar C, Mitsudomi T, Mok TSK, Yang JC, Hoyle C ( 2018 )
Clinical Drug Investigation
Publication in refereed journal
典藏於此文庫的全文:
file.pdf
數位物件識別號 (DOI): http://dx.doi.org/10.1007/s40261-017-0611-3
A feasibility study on using tablet personal computers for self‐reported symptom assessment in newly diagnosed lung cancer patients
Fiona W.K. Tang, Carmen W.H. Chan, Yin‐Ping Choy, Herbert H.F. Loong, Ka Ming Chow, Winnie K.W. So ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1111/ijn.12658
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study
Li J, Xu RH, Qin SK, Liu TS, Pan HM, Xu JM, Bi F, Lim R, Zhang SZ, Ba Y, Bai YX, Fan NF, Tsuji A, Yeh KH, Ma B, Wei V, Shi DM, Magherini E, Shen L, Shen L ( 2018 )
Future Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.2217/fon-2017-0669
Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma
Charing Ching-Ning Chong, Anthony Wing-Hung Chan, John Wong, Cheuk-Man Chu, Stephen Lam Chan, Kit-Fai Lee, Simon Chun-Ho Yu, Ka-Fai To, Philip Johnson, Paul Bo-San Lai ( 2018 )
Surgeon
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1016/j.surge.2017.07.003
Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial
Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheng ACK, Ng WT, Lee VHF, Ma BBY, Cheng HC, Wong FCS, Loong HHF, Tong M, Poon DMC, Ahuja AT, King AD, Wang K, Mo F, Zee BCY, Chan KCA, Lo YMD ( 2018 )
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.77.7847
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Brigette B.Y. Ma, Wan-Teck Lim, Boon-Cher Goh, Edwin P. Hui, Kwok-Wai Lo, Adam Pettinger, Nathan R. Foster, Jonathan W. Riess, Mark Agulnik, Alex Y.C. Chang, Akhil Chopra, Julie A. Kish, Christine H. Chung, Douglas R. Adkins, Kevin J. Cullen, Barbara J. Gitlitz, Dean W. Lim, Ka-Fai To, K.C. Allen Chan, Y.M. Dennis Lo, Ann D. King, Charles Erlichman, Jun Yin, Brian A. Costello, Anthony T.C. Chan ( 2018 )
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2017.77.0388
A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study
Abou-Alfa GK, Chan SL, Furuse J, Galle PR, Kelley RK, Qin SK ( 2018 )
JOURNAL OF CLINICAL ONCOLOGY
Publication in refereed journal
數位物件識別號 (DOI): http://dx.doi.org/10.1200/JCO.2018.36.15_suppl.TPS4144

10 | 25 | 50 | 100

1/9

研究成果 (81)

分享連結

Our policy towards the use of cookies